Bioventus appoints Ajay Dhankhar to board as Smith & Nephew designee

Bioventus Inc.

Appointment effective November 14, 2025; Dhankhar serves as Class II director until 2026 annual meeting.
Dhankhar is Chief Corporate Development & Strategy Officer at Smith & Nephew (SNN) since June 2025.
He is the second designee from S+N stockholders under the Stockholders Agreement.
Dhankhar will not receive any compensation from Bioventus for board service.
No family relationships or material interests in any transaction with the Company.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.